Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥20.19 - CN¥41.78
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CN¥8.50B |
EV | CN¥8.45B |
Shares Outstanding | 413.66M |
Beta | -0.01 |
Analyst Rating | BUY |
Analyst Target Price | CN¥32.00 |
P/E 2025E | 10.05x |
P/Revenue 2025E | 3.17x |
Revenue | 0.70% |
EPS | -3.30% |
Operating Cash Flow | 42.60% |
Free Cash Flow | 27.40% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 91.80% |
Net Profit Margin 2025E | 31.52% |
ROE 2025E | 15.97% |
ROCE 2024 | 5.63% |
DPS 2025E | CN¥0.19 |
Payout Ratio 2025E | 9.31% |
Div. Yield 2025E | 0.93% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Changchun BCHT Biotechnology Co.
688276
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kong, Wei
Employees
1,241
Website
www.bchtpharm.comIPO Date
2021-06-25
Headquarters
No. 138, Zhuoyue Street, Chaoyang District, Changchun, Jilin Province, 130103, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved